<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-04977903</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-15T04:44:51+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis</title>
            <author role="aut">
              <persName>
                <forename type="first">Andreas</forename>
                <surname>Kerschbaumer</surname>
              </persName>
              <idno type="halauthorid">2284048-0</idno>
              <affiliation ref="#struct-93275"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Josef</forename>
                <surname>Smolen</surname>
              </persName>
              <idno type="halauthorid">982540-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Ricardo</forename>
                <surname>Ferreira</surname>
              </persName>
              <idno type="halauthorid">2071252-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Heidi</forename>
                <surname>Bertheussen</surname>
              </persName>
              <idno type="halauthorid">2668246-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Xenofon</forename>
                <surname>Baraliakos</surname>
              </persName>
              <idno type="halauthorid">1747502-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Daniel</forename>
                <surname>Aletaha</surname>
              </persName>
              <idno type="halauthorid">1197723-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Dennis</forename>
                <surname>Mcgonagle</surname>
              </persName>
              <idno type="halauthorid">2506646-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Désirée</forename>
                <surname>van der Heijde</surname>
              </persName>
              <idno type="halauthorid">2530041-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Iain</forename>
                <surname>Mcinnes</surname>
              </persName>
              <idno type="halauthorid">1198550-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Bente Appel</forename>
                <surname>Esbensen</surname>
              </persName>
              <idno type="halauthorid">2204795-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Kevin</forename>
                <surname>Winthrop</surname>
              </persName>
              <idno type="halauthorid">2020460-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Wolf-Henning</forename>
                <surname>Boehncke</surname>
              </persName>
              <idno type="halauthorid">2495484-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Jan</forename>
                <surname>Schoones</surname>
              </persName>
              <idno type="halauthorid">3437850-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Laure</forename>
                <surname>Gossec</surname>
              </persName>
              <email type="md5">c8c06cfad576146e8beadf6a5b073459</email>
              <email type="domain">cch.aphp.fr</email>
              <idno type="idhal" notation="string">lauregossec</idno>
              <idno type="idhal" notation="numeric">984216</idno>
              <idno type="halauthorid" notation="string">253090-984216</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-4528-310X</idno>
              <idno type="IDREF">https://www.idref.fr/061096504</idno>
              <affiliation ref="#struct-1082239"/>
              <affiliation ref="#struct-353778"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Laure</forename>
                <surname>Gossec</surname>
              </persName>
              <email type="md5">755e1186143ad1e74b61df015480ff1e</email>
              <email type="domain">aphp.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2025-03-05 12:51:17</date>
              <date type="whenModified">2026-01-09 14:46:03</date>
              <date type="whenReleased">2025-03-05 15:43:20</date>
              <date type="whenProduced">2024-06</date>
              <date type="whenEndEmbargoed">2025-03-05</date>
              <ref type="file" target="https://hal.science/hal-04977903v1/document">
                <date notBefore="2025-03-05"/>
              </ref>
              <ref type="file" subtype="author" n="1" target="https://hal.science/hal-04977903v1/file/psa-recos2023-slr-manuscript-clean-final.pdf" id="file-4977903-4315169">
                <date notBefore="2025-03-05"/>
              </ref>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="372069">
                <persName>
                  <forename>Laure</forename>
                  <surname>Gossec</surname>
                </persName>
                <email type="md5">755e1186143ad1e74b61df015480ff1e</email>
                <email type="domain">aphp.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-04977903</idno>
            <idno type="halUri">https://hal.science/hal-04977903</idno>
            <idno type="halBibtex">kerschbaumer:hal-04977903</idno>
            <idno type="halRefHtml">&lt;i&gt;Annals of the Rheumatic Diseases&lt;/i&gt;, 2024, 83 (6), pp.760-774. &lt;a target="_blank" href="https://dx.doi.org/10.1136/ard-2024-225534"&gt;&amp;#x27E8;10.1136/ard-2024-225534&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Annals of the Rheumatic Diseases, 2024, 83 (6), pp.760-774. &amp;#x27E8;10.1136/ard-2024-225534&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 - Attribution<ref corresp="#file-4977903-4315169"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="APHP" corresp="INSERM">AP-HP</idno>
            <idno type="stamp" n="IPLESP" corresp="SORBONNE-UNIVERSITE">Institut Pierre Louis d'Epidémiologie et de Santé Publique</idno>
            <idno type="stamp" n="SORBONNE-UNIVERSITE">Sorbonne Université</idno>
            <idno type="stamp" n="SORBONNE-UNIV" corresp="SORBONNE-UNIVERSITE">Sorbonne Université 01/01/2018</idno>
            <idno type="stamp" n="SU-MEDECINE" corresp="SORBONNE-UNIVERSITE">Faculté de Santé de Sorbonne Université</idno>
            <idno type="stamp" n="SU-MED" corresp="SORBONNE-UNIVERSITE">Médecine - Sorbonne Université</idno>
            <idno type="stamp" n="SU-TI">Sorbonne Université - Texte Intégral</idno>
            <idno type="stamp" n="ALLIANCE-SU"> Alliance Sorbonne Université</idno>
            <idno type="stamp" n="SUPRA_MEDECINE_AUTRE">Médecine (hors SVE6)</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Andreas</forename>
                    <surname>Kerschbaumer</surname>
                  </persName>
                  <idno type="halauthorid">2284048-0</idno>
                  <affiliation ref="#struct-93275"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Josef</forename>
                    <surname>Smolen</surname>
                  </persName>
                  <idno type="halauthorid">982540-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Ricardo</forename>
                    <surname>Ferreira</surname>
                  </persName>
                  <idno type="halauthorid">2071252-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Heidi</forename>
                    <surname>Bertheussen</surname>
                  </persName>
                  <idno type="halauthorid">2668246-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Xenofon</forename>
                    <surname>Baraliakos</surname>
                  </persName>
                  <idno type="halauthorid">1747502-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Daniel</forename>
                    <surname>Aletaha</surname>
                  </persName>
                  <idno type="halauthorid">1197723-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Dennis</forename>
                    <surname>Mcgonagle</surname>
                  </persName>
                  <idno type="halauthorid">2506646-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Désirée</forename>
                    <surname>van der Heijde</surname>
                  </persName>
                  <idno type="halauthorid">2530041-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Iain</forename>
                    <surname>Mcinnes</surname>
                  </persName>
                  <idno type="halauthorid">1198550-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Bente Appel</forename>
                    <surname>Esbensen</surname>
                  </persName>
                  <idno type="halauthorid">2204795-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Kevin</forename>
                    <surname>Winthrop</surname>
                  </persName>
                  <idno type="halauthorid">2020460-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Wolf-Henning</forename>
                    <surname>Boehncke</surname>
                  </persName>
                  <idno type="halauthorid">2495484-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Jan</forename>
                    <surname>Schoones</surname>
                  </persName>
                  <idno type="halauthorid">3437850-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Laure</forename>
                    <surname>Gossec</surname>
                  </persName>
                  <email type="md5">c8c06cfad576146e8beadf6a5b073459</email>
                  <email type="domain">cch.aphp.fr</email>
                  <idno type="idhal" notation="string">lauregossec</idno>
                  <idno type="idhal" notation="numeric">984216</idno>
                  <idno type="halauthorid" notation="string">253090-984216</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-4528-310X</idno>
                  <idno type="IDREF">https://www.idref.fr/061096504</idno>
                  <affiliation ref="#struct-1082239"/>
                  <affiliation ref="#struct-353778"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">10511</idno>
                <idno type="issn">0003-4967</idno>
                <idno type="eissn">1468-2060</idno>
                <title level="j">Annals of the Rheumatic Diseases</title>
                <imprint>
                  <publisher>BMJ Publishing Group</publisher>
                  <biblScope unit="volume">83</biblScope>
                  <biblScope unit="issue">6</biblScope>
                  <biblScope unit="pp">760-774</biblScope>
                  <date type="datePub">2024-06</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1136/ard-2024-225534</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">psoriatic arthritis DMARDs (biological) DMARDs (synthetic) treatment algorithms recommendations</term>
                <term xml:lang="en">psoriatic arthritis</term>
                <term xml:lang="en">DMARDs (biological)</term>
                <term xml:lang="en">DMARDs (synthetic)</term>
                <term xml:lang="en">treatment algorithms</term>
                <term xml:lang="en">recommendations</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Objectives: To obtain an overview of recent evidence on efficacy and safety of pharmacological treatments in psoriatic arthritis (PsA). Methods: This systematic literature research (SLR) investigated the efficacy and safety of conventional synthetic (cs), biological (b) and targeted synthetic (ts)DMARDs in patients with PsA. A systematic database search utilizing Medline, EMBASE, Cochrane CENTRAL was conducted to identify relevant articles published since the previous update in 2019 until December 28th, 2022. Efficacy was assessed in trials while for safety observational data was also considered. Adverse events of special interest were infections (including herpes zoster, influenza and tuberculosis), malignancies, major adverse cardiovascular events, venous thromboembolisms, liver disease, laboratory changes, and psychiatric adverse events. No meta-analyses were performed. Results: For efficacy, of 3946 articles screened, 38 articles (30 trials) were analysed. The compounds investigated included csDMARDs (leflunomide, methotrexate), bDMARDs inhibiting IL17 (bimekizumab, brodalumab, ixekizumab, izokibep, secukinumab,), IL-23 (guselkumab, risankizumab, tildrakizumab), IL-12/23 (ustekinumab) as well as TNF (adalimumab, certolizumab-pegol, etanercept, infliximab, golimumab) and Janus Kinase inhibitors (brepocitinib, deucravacitinib, tofacitinib, upadacitinib). The compounds investigated were efficacious in improving signs and symptoms of PsA, improving physical functioning and quality of life. For safety, 2055 abstracts were screened, and 24 articles analysed: 15 observational studies and 9 long-term follow-ups of trials, assessing glucocorticoids, TNFi, IL-17i, JAKi, IL-12/23i and PDE4i (apremilast). Safety indicators were generally coherent with the previous SLR in 2019. Conclusion: The results of this SLR informed the taskforce responsible for the 2023 update of the EULAR recommendations for pharmacologic management of PsA.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="institution" xml:id="struct-93275" status="VALID">
          <idno type="ROR">https://ror.org/05n3x4p02</idno>
          <orgName>Medical University of Vienna = Medizinische Universität Wien</orgName>
          <orgName type="acronym">MedUni Vienna</orgName>
          <desc>
            <address>
              <addrLine>Spitalgasse 23, A-1090 Vienna</addrLine>
              <country key="AT"/>
            </address>
            <ref type="url">https://www.meduniwien.ac.at/web/en/</ref>
          </desc>
        </org>
        <org type="researchteam" xml:id="struct-1082239" status="VALID">
          <orgName>Pharmacoépidémiologie et évaluation des soins [iPLesp]</orgName>
          <orgName type="acronym">PEPITES</orgName>
          <desc>
            <address>
              <addrLine>27 rue Chaligny, 75012 Paris - France</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.iplesp.upmc.fr/fr/team/PEPITES</ref>
          </desc>
          <listRelation>
            <relation active="#struct-542132" type="direct"/>
            <relation name="U1136" active="#struct-303623" type="indirect"/>
            <relation active="#struct-413221" type="indirect"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-353778" status="VALID">
          <idno type="ROR">https://ror.org/02mh9a093</idno>
          <orgName>CHU Pitié-Salpêtrière [AP-HP]</orgName>
          <desc>
            <address>
              <addrLine>47-83 Boulevard de l'Hôpital, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.aphp.fr/contenu/hopital-universitaire-pitie-salpetriere-0</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300068" type="direct"/>
            <relation active="#struct-413221" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-542132" status="VALID">
          <idno type="IdRef">186433786</idno>
          <idno type="RNSR">201420917E</idno>
          <orgName>Institut Pierre Louis d'Epidémiologie et de Santé Publique</orgName>
          <orgName type="acronym">iPLESP</orgName>
          <desc>
            <address>
              <addrLine>56, boulevard Vincent Auriol - CS 81393 - 75646 Paris Cedex 13</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.iplesp.upmc.fr/</ref>
          </desc>
          <listRelation>
            <relation name="U1136" active="#struct-303623" type="direct"/>
            <relation active="#struct-413221" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-413221" status="VALID">
          <idno type="IdRef">221333754</idno>
          <idno type="ROR">https://ror.org/02en5vm52</idno>
          <orgName>Sorbonne Université</orgName>
          <orgName type="acronym">SU</orgName>
          <date type="start">2018-01-01</date>
          <desc>
            <address>
              <addrLine>21 rue de l’École de médecine - 75006 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.sorbonne-universite.fr/</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-300068" status="VALID">
          <idno type="ROR">https://ror.org/00pg5jh14</idno>
          <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
          <orgName type="acronym">AP-HP</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>